Freeport-Mcmoran Inc: Form 10-Q for the period ended Sep 30, 2022
Filed with the SEC on Nov 4, 2022 and accepted by EDGAR at Nov 4, 2022, 15:13 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-07-01 to 2022-09-30 | $5.31bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2022-01-01 to 2022-09-30 | $17.84bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2022-07-01 to 2022-09-30 | $3.90bn | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2022-01-01 to 2022-09-30 | $11.07bn | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months2022-07-01 to 2022-09-30 | $98.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2022-01-01 to 2022-09-30 | $313.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-07-01 to 2022-09-30 | $962.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2022-01-01 to 2022-09-30 | $5.51bn | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2022-07-01 to 2022-09-30 | $315.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2022-01-01 to 2022-09-30 | $1.71bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-07-01 to 2022-09-30 | $560.0m | us-gaap:ProfitLoss |
| Net income | 9 months2022-01-01 to 2022-09-30 | $3.50bn | us-gaap:ProfitLoss |
| Diluted EPS | 3 months2022-07-01 to 2022-09-30 | $0.28 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2022-01-01 to 2022-09-30 | $1.90 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-07-01 to 2022-09-30 | $0.28 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2022-01-01 to 2022-09-30 | $1.91 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-07-01 to 2022-09-30 | 1,439,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2022-01-01 to 2022-09-30 | 1,455,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2022-01-01 to 2022-09-30 | $4.07bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2022-07-01 to 2022-09-30 | $836.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Capital expenditure | 9 months2022-01-01 to 2022-09-30 | $2.42bn | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 9 months2022-01-01 to 2022-09-30 | $652.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2022-01-01 to 2022-09-30 | $1.35bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-09-30 | $8.58bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-09-30 | $15.37bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-09-30 | $49.93bn | us-gaap:Assets |
| Current liabilities | At period end2022-09-30 | $6.00bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-09-30 | $25.75bn | us-gaap:Liabilities |
| Long-term debt | At period end2022-09-30 | $9.66bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2022-09-30 | $1.03bn | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2022-09-30 | $14.95bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000831259-22-000049. Last ingested by Listed: Nov 6, 2026, 13:42 ET. Listed shows no prices and gives no investment advice.